NR602 FINAL EXAM 2026 REVIEW WITH
COMPLETE REAL EXAM QUESTIONS AND
CORRECT VERIFIED ANSWERS/ ALREADY
GRADED A+ (MOST RECENT!!)
NR602 FINAL EXAM REVIEW
Primary Care of the Childbearing & Childrearing Family
Total Questions: 200
Format: Multiple Choice
Passing Score: 85% (170 correct)
Time Limit: 4 hours
Section 1: Well-Woman Care & Preventive Health (Questions 1–25)
1. According to USPSTF, at what age should routine cervical cancer screening
(Pap test) begin?
A) Age 18
B) Age 21
C) Age 25
D) Age 30
Answer: B
Rationale: USPSTF and ACOG recommend first Pap test at age 21 regardless
of sexual history. Screening before 21 leads to unnecessary procedures
without benefit.
2. How often should a woman aged 25 with normal Pap and negative HPV
co-testing be screened?
A) Every year
B) Every 3 years (Pap alone) or every 5 years (Pap + HPV co-testing)
,C) Every 6 months
D) No further screening
Answer: B
*Rationale: Ages 21-29: Pap alone every 3 years. Ages 30-65: Pap + HPV co-
testing every 5 years OR Pap alone every 3 years.*
3. A 28-year-old woman has a Pap result of ASC-US (atypical squamous cells
of undetermined significance). HPV testing is negative. What is the
recommended management?
A) Colposcopy immediately
B) Repeat Pap in 3 years
C) Repeat Pap in 1 year
D) LEEP procedure
Answer: C
*Rationale: ASC-US with negative HPV → repeat co-testing in 1 year (or Pap
alone in 3 years). ASC-US with positive HPV → colposcopy.*
4. Which of the following is NOT a component of the well-woman exam
recommended annually?
A) Blood pressure measurement
B) BMI screening
C) Pelvic exam with bimanual palpation (if asymptomatic, not required
annually)
D) Depression screening
Answer: C
Rationale: Pelvic exam in asymptomatic, non-pregnant women is not
recommended annually. USPSTF states insufficient evidence for routine
pelvic exam.
5. USPSTF recommends screening for chlamydia in sexually active women
under age:
A) 18
B) 21
C) 25
,D) 30
Answer: C
Rationale: Screen all sexually active women ≤25 years and older women at
increased risk (new partner, multiple partners, inconsistent condom use).
6. A 45-year-old woman has a BRCA1 mutation. What is the recommended
breast cancer screening?
A) Mammogram starting at age 50
B) Annual mammogram + breast MRI starting at age 30
C) Clinical breast exam only
D) No screening
Answer: B
*Rationale: High-risk women (BRCA1/2, strong family history) should have
annual mammogram + breast MRI starting at age 30-35 (or earlier depending
on family history).*
7. A 55-year-old woman has a bone density T-score of -2.5 at the femoral
neck. What is the diagnosis?
A) Normal
B) Osteopenia
C) Osteoporosis
D) Osteomalacia
Answer: C
*Rationale: T-score: Normal > -1.0, Osteopenia -1.0 to -2.4, Osteoporosis ≤ -
2.5. FRAX tool assesses fracture risk.*
8. Which vaccine is recommended for all pregnant women during each
pregnancy regardless of prior vaccination?
A) MMR
B) Tdap (between 27-36 weeks)
C) HPV
D) Varicella
Answer: B
, *Rationale: Tdap (tetanus, diphtheria, acellular pertussis) is given each
pregnancy (optimally 27-36 weeks) to pass antibodies to the newborn.*
9. A 30-year-old woman with no prior Pap history has an HPV 16/18 positive
test with normal cytology. What is the next step?
A) Repeat co-testing in 1 year
B) Colposcopy
C) HPV vaccine
D) Repeat Pap in 3 years
Answer: B
*Rationale: HPV 16/18 are high-risk oncogenic types. Even with normal
cytology, colposcopy is indicated due to high risk of CIN 3.*
10. Which of the following is a contraindication to combined oral
contraceptives (COCs)?
A) Age >35 and smoking ≥15 cigarettes/day
B) Migraine without aura
C) Obesity (BMI >30)
D) Depression
Answer: A
*Rationale: Age >35 + smoking ≥15/day → high risk of VTE, stroke, MI. COCs
are contraindicated (WHO MEC Category 4).*
11. A 22-year-old woman requests emergency contraception 48 hours after
unprotected intercourse. What is the most effective option?
A) Copper IUD (can be inserted up to 5 days)
B) Levonorgestrel (Plan B)
C) Ulipristal acetate (Ella)
D) Yuzpe method
Answer: A
Rationale: Copper IUD is >99% effective and provides ongoing
contraception. Levonorgestrel (≤72h) and ulipristal (≤120h) are less effective.
12. A 50-year-old perimenopausal woman has hot flashes and night sweats
but has a history of breast cancer. Which therapy is contraindicated?
COMPLETE REAL EXAM QUESTIONS AND
CORRECT VERIFIED ANSWERS/ ALREADY
GRADED A+ (MOST RECENT!!)
NR602 FINAL EXAM REVIEW
Primary Care of the Childbearing & Childrearing Family
Total Questions: 200
Format: Multiple Choice
Passing Score: 85% (170 correct)
Time Limit: 4 hours
Section 1: Well-Woman Care & Preventive Health (Questions 1–25)
1. According to USPSTF, at what age should routine cervical cancer screening
(Pap test) begin?
A) Age 18
B) Age 21
C) Age 25
D) Age 30
Answer: B
Rationale: USPSTF and ACOG recommend first Pap test at age 21 regardless
of sexual history. Screening before 21 leads to unnecessary procedures
without benefit.
2. How often should a woman aged 25 with normal Pap and negative HPV
co-testing be screened?
A) Every year
B) Every 3 years (Pap alone) or every 5 years (Pap + HPV co-testing)
,C) Every 6 months
D) No further screening
Answer: B
*Rationale: Ages 21-29: Pap alone every 3 years. Ages 30-65: Pap + HPV co-
testing every 5 years OR Pap alone every 3 years.*
3. A 28-year-old woman has a Pap result of ASC-US (atypical squamous cells
of undetermined significance). HPV testing is negative. What is the
recommended management?
A) Colposcopy immediately
B) Repeat Pap in 3 years
C) Repeat Pap in 1 year
D) LEEP procedure
Answer: C
*Rationale: ASC-US with negative HPV → repeat co-testing in 1 year (or Pap
alone in 3 years). ASC-US with positive HPV → colposcopy.*
4. Which of the following is NOT a component of the well-woman exam
recommended annually?
A) Blood pressure measurement
B) BMI screening
C) Pelvic exam with bimanual palpation (if asymptomatic, not required
annually)
D) Depression screening
Answer: C
Rationale: Pelvic exam in asymptomatic, non-pregnant women is not
recommended annually. USPSTF states insufficient evidence for routine
pelvic exam.
5. USPSTF recommends screening for chlamydia in sexually active women
under age:
A) 18
B) 21
C) 25
,D) 30
Answer: C
Rationale: Screen all sexually active women ≤25 years and older women at
increased risk (new partner, multiple partners, inconsistent condom use).
6. A 45-year-old woman has a BRCA1 mutation. What is the recommended
breast cancer screening?
A) Mammogram starting at age 50
B) Annual mammogram + breast MRI starting at age 30
C) Clinical breast exam only
D) No screening
Answer: B
*Rationale: High-risk women (BRCA1/2, strong family history) should have
annual mammogram + breast MRI starting at age 30-35 (or earlier depending
on family history).*
7. A 55-year-old woman has a bone density T-score of -2.5 at the femoral
neck. What is the diagnosis?
A) Normal
B) Osteopenia
C) Osteoporosis
D) Osteomalacia
Answer: C
*Rationale: T-score: Normal > -1.0, Osteopenia -1.0 to -2.4, Osteoporosis ≤ -
2.5. FRAX tool assesses fracture risk.*
8. Which vaccine is recommended for all pregnant women during each
pregnancy regardless of prior vaccination?
A) MMR
B) Tdap (between 27-36 weeks)
C) HPV
D) Varicella
Answer: B
, *Rationale: Tdap (tetanus, diphtheria, acellular pertussis) is given each
pregnancy (optimally 27-36 weeks) to pass antibodies to the newborn.*
9. A 30-year-old woman with no prior Pap history has an HPV 16/18 positive
test with normal cytology. What is the next step?
A) Repeat co-testing in 1 year
B) Colposcopy
C) HPV vaccine
D) Repeat Pap in 3 years
Answer: B
*Rationale: HPV 16/18 are high-risk oncogenic types. Even with normal
cytology, colposcopy is indicated due to high risk of CIN 3.*
10. Which of the following is a contraindication to combined oral
contraceptives (COCs)?
A) Age >35 and smoking ≥15 cigarettes/day
B) Migraine without aura
C) Obesity (BMI >30)
D) Depression
Answer: A
*Rationale: Age >35 + smoking ≥15/day → high risk of VTE, stroke, MI. COCs
are contraindicated (WHO MEC Category 4).*
11. A 22-year-old woman requests emergency contraception 48 hours after
unprotected intercourse. What is the most effective option?
A) Copper IUD (can be inserted up to 5 days)
B) Levonorgestrel (Plan B)
C) Ulipristal acetate (Ella)
D) Yuzpe method
Answer: A
Rationale: Copper IUD is >99% effective and provides ongoing
contraception. Levonorgestrel (≤72h) and ulipristal (≤120h) are less effective.
12. A 50-year-old perimenopausal woman has hot flashes and night sweats
but has a history of breast cancer. Which therapy is contraindicated?
